Key result
Two cases of myxofibrosarcoma of the heart were described, one with a background of inflammatory myofibroblastic tumor and another with a history of breast cancer and diffuse large B-cell lymphoma.
Why the study?
Intraluminal formations of the heart are heterogeneous and require morphological research to determine nosology, with myxofibrosarcoma of the heart representing a rare malignant tumor.
Case Report (n=2)
This case series describes two rare instances of cardiac myxofibrosarcoma, highlighting its presentation in patients with complex oncological or inflammatory histories.
Answers are grounded in this paper and cite their sources.
Supports consideration of myxofibrosarcoma in atypical cardiac masses with oncologic or inflammatory history; leaves open questions on etiology and management.
Intraluminal formations of the heart are a heterogeneous group: from blood clots to malignant neoplasms. The nosology of these formations can only be determined by morphological research. Myxofibrosarcoma of the heart is a rare malignant tumor. According to modern concepts, myxofibrosarcoma belongs to the group of intimal sarcomas, subgroup of undifferentiated pleomorphic sarcomas. We describe two cases of myxofibrosarcoma of the heart: in one subject against the background of inflammatory myofibroblastic heart tumor; in another subject - with a history of breast cancer and diffuse large B-cell lymphoma. An attempt was made to identify similar mutations in patients with these tumors according to the literature.
No takes yet. Share an insight, caveat, or question.
Makarov et al. (2022) conducted a case report in Myxofibrosarcoma of the heart (n=2). Myxofibrosarcoma of the heart was evaluated. Two cases of myxofibrosarcoma of the heart were described, one with a background of inflammatory myofibroblastic tumor and another with a history of breast cancer and diffuse large B-cell lymphoma.
Synapse has enriched 10 related papers. Consider them for comparative context: